Joseph P. Slattery - 16 Jun 2026 Form 4 Insider Report for ImageneBio, Inc. (IMA)

Reporting relationship: Director
Issuer ticker: IMA
Reported as of: 16 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Jun 2026, 18:45:12 UTC
Prior SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Kristin Yarema, Attorney-in-Fact

Key filing fact

Joseph P. Slattery filed Form 4 for ImageneBio, Inc. (IMA) on 18 Jun 2026.

Key facts

This page summarizes Joseph P. Slattery's Form 4 filing for ImageneBio, Inc. (IMA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 Jun 2026, 18:45.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001246530 Primary reporting owner

SLATTERY JOSEPH P

Relationship: Director
Address: C/O IMAGENEBIO, INC., 2526 HIGH BLUFF DRIVE, SAN DIEGO
Signature: /s/ Kristin Yarema, Attorney-in-Fact
Signature date: 18 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMA transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +15,600
Change %
Price: $0.000000^*
Shares after: 15,600
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,600
Exercise price: $5.45
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares vest in full upon the earlier to occur of the first anniversary of the date of grant, the date of the Issuer's next annual meeting or a change of control as defined in the Issuer's 2025 Equity Incentive Plan.